2 results about "Trachelospermum" patented technology

1. Name of the product in this design: Packaging Box (Trachelospermum jasminoides antibacterial powder). 2. Intended use of this design: for product packaging, especially for the packaging of Trachelospermum jasminoides antibacterial powder. 3. The key design features of this product are the combination of pattern and color. 4. The image or photograph that best illustrates the design's key points: the front view. 5. The design for which protection is sought includes color.

The invention relates to an external traditional Chinese medicine composition for treating cold coagulation and blood stasis type diabetic peripheral neuropathy. The traditional Chinese medicine composition is prepared from the following raw materials in parts by weight: 28-32 parts of prepared rehmannia root, 18-22 parts of dried ginger, 28-32 parts of peach kernel, 28-32 parts of safflower, 28-32 parts of angelica sinensis, 28-32 parts of ligusticum wallichii, 28-32 parts of radix cyathulae, 13-17 parts of leech, 28-32 parts of earthworm, 28-32 parts of mulberry twig, 13-17 parts of asarum, 28-32 parts of Chinese starjasmine stem, 28-32 parts of roasted ephedra and 28-32 parts of cassia twig. The invention further provides application of the traditional Chinese medicine composition in preparation of a medicine for treating cold coagulation and blood stasis type diabetic peripheral neuropathy. From the perspective of traditional Chinese medicine, the arthralgia relieving prescription can act on the pathogenesis of DPN, and cold coagulation and blood stasis toxin blocking meridians of the body of a patient are eliminated; from the perspective of western medicine, the formula can act on the pathogenesis of DPN, inhibit the inflammatory response of the human body, remove oxygen free radicals, regulate the microcirculation of the human body and further protect nerves. In conclusion, the arthralgia dredging ointment can improve the traditional Chinese medicine syndromes of the DPN patients, reduce the Toronto score and improve the nerve conduction velocity of the DPN patients.